Targeting NR2A-containing NMDA receptors reduces L-DOPA-induced dyskinesias. [electronic resource]
Producer: 20121129Description: 2138-44 p. digitalISSN:- 1558-1497
- Adrenergic Agents -- toxicity
- Analysis of Variance
- Animals
- Antiparkinson Agents -- adverse effects
- Calcium-Calmodulin-Dependent Protein Kinase Type 2 -- metabolism
- Disease Models, Animal
- Disks Large Homolog 4 Protein
- Dyskinesia, Drug-Induced -- drug therapy
- Gene Expression Regulation -- drug effects
- Intracellular Signaling Peptides and Proteins -- metabolism
- Levodopa -- adverse effects
- Male
- Medial Forebrain Bundle -- drug effects
- Membrane Proteins -- metabolism
- Oxidopamine -- toxicity
- Parkinson Disease -- drug therapy
- Rats
- Rats, Wistar
- Receptors, N-Methyl-D-Aspartate -- metabolism
- Subcellular Fractions
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.